FDA approves remdesivir for COVID-19 patients
October 23, 2020
SAN ANTONIO (Oct. 23, 2020) — The U.S. Food and Drug Administration announced Oct. 22 that the drug remdesivir (Veklury) is the first approved treatment for COVID-19. The antiviral medication has been tested in study sites internationally since February, including a study site led by UT Health San Antonio and its clinical partner, University Health […]
